This leads us to speculate that APOBEC3A—having tumor-suppressive functions in HPV+ disease—is not responsible for APOBEC-induced mutational signatures correlated with worse outcomes in HPV+ PSCs. The gene discussed is APOBEC3A; the disease is neoplasm.